Elevated soluble tumor necrosis factor receptor levels in seasonal allergic rhinitis patients

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 3, 1999, Pages 278-282

  Kato, M ^a,b   Hattori, T ^a,b   Kato, Y ^a,b   Matsumoto, Y ^a,b   Yamashita, T ^a,b   Nakashima, I ^a,b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Allergic rhinitis; Natural allergen provocation; Soluble tumor necrosis factor receptor; Tumor necrosis factor

Indexed keywords

PROTEIN P55; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; HUMAN; NOSE MUCOSA; NOSE SMEAR; POLLEN ALLERGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEASONAL VARIATION;

ADULT; ALLERGENS; HUMANS; JAPAN; NASAL LAVAGE FLUID; NASAL MUCOSA; POLLEN; RECEPTORS, TUMOR NECROSIS FACTOR; RHINITIS, ALLERGIC, SEASONAL; TREES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033012964     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00942.x     Document Type: Article

References (25)

1. Bachert C, Häuser U, Prem B, Rudack C, Ganzer U. Proinflammatory cytokines in allergie rhinitis. EUT Arch Otoihinolaryngol 1995;î5î Suppl 1:844-49.
2. Kato M, Hattori T, Kitamura M, Bcppu R, Yanagita N, Nakashima I. Soluble ICAM-i as a regulator of nasal allergic reaction under natural allergen provocation. Clin Exp Allergy 1995;2s:744-748.
3. Kalo M, Hattori T, Ikcda R, et al. Numbers of pollen have an effect on the systemic and local levels of soluble ICAM-i from patients with seasonal allergic rhinitis. Allergy 1996;5i:ii8-i3i.
4. Kato M, Hattori T, Matsumoto Y, Nakashima I. Dynamics of soluble adhesion molecules level in patients with pollinosis. Arch Otolaryngol 1996;i22:i398-i4oo.
5. Kato M, Hattori T, Yamashita T, Kurimoto F, "Liu W, Nakashima I. Evidence of potential regulation by intcrlcukin 4 of the soluble intercellular adhesion molecule-i level in patients with seasonal allergic rhinitis under provocation by a small amount of natural allergen. Ann Otol Rhinol Laryngol 1998;107:232-235.
6. Bcvilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule i: an inducible receptor for ncutrophils related to complement regulatory proteins and lectins. Science I989;243:n6o1165.
7. Osborn L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule i, a cytokinc-induced endothelial protein that binds to lymphocytes. Cell 1989;59:i2O3-i2ii.
8. Pober JS, Gimbrone MA, Lapierre LA, et al. Overlapping patterns of activation of human endothelial cells by interleukin i, tumor necrosis factor, and immune interferon. //nimuno/I986;i37:i893-i896.
9. Tartaglia LA, Goeddcl DV. Two TNF receptors. Immunol Today 1992;i3:i5i-is3.
10. Okamoto Y, Shirotori K, Kudo K, et al. Cytokine expression after the topical administration of substance P to human nasal mucosa. / Immunol i993;isi:439i-4398.
11. Olsson I, Lantz M, Nilsson E, et al. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur J Haematol 1989;4ï:27O-275.
12. Scckingcr P, Isaaz S, Dayer JM. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. / Biol Chem I989;i64:i 1966-11973.
13. van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawcr LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-a in vitro and in vivo. Pioc Natl Acad Sei USA i99Z;89:4845-4849.
14. Higuchi M, Aggarwal BB. Inhibition of ligand and antiproliferative effects of tumor necrosis factor and lymphotoxin by soluble forms of rccombinant P6o and P8o receptors. Biochem Biophys Res Commun 1992;i8i:638-643.
15. Lesslauer VV, Tabuchi H, Gcntz R, et al. Rccombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharidc-induced lethality. EUT J Immunol 199i;ii:î883-i886.
16. Sclmaj K, Papicrz W, Glabinski A, Kohno T. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. / Nemoimmunol 1995)56:135-141.
17. Kaulbach HC, White MV, Igarashi Y, Hahn BK, Kaliner MA. Estimation of nasal epithelial lining fluid using urea as a marker. / Alleigy Clin Immunol 1993)92:457-465.
18. Hallett CJ, Cook JGH. Reduced nicotinamide adcnine dinucleotide-couplcd reaction for emergency blood urea estimation. Clin Chim Acta 197i;3S:33-37.
19. Kalo M, Hattori T, Takahashi M, Nakashiraa I, Yanagita N. Eosinophil cationic protein (ECP) and prophylactic treatment in pollinosis in natural allergen provocation. Br J Clin Pract 1994;48:i99-3Oi.
20. Kato M, Hattori T, Kitamura M, Beppu R, Yanagita N, Nakashima I. Major basic protein (MBP) and topical administration of ketotifen in pollinosis under natural allergen provocation. ORL 19gSiS7:19-72
21. Spinas GA, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxemia. / Clin Invest 1992)90:533-536.
22. Nonaka M, Nonaka R, fordana M, Dolovich J. GM-CSF, IL-8, IL-iR, TNF-aR, and HLA-DR in nasal epithelial cells in allergic rhinitis. Am J Respir Ciit Care Med 1996; 153:1675-1681.
23. Laan MP, Koning H, Baert MRM, et al. Levels of soluble intercellular adhesion molecule-i, soluble E-selectin, tumor necrosis factor-a, and soluble tumor necrosis factor receptor P55 and p75 in atopic children. Allergy 1998;53:5i-58-
24. Ulich TR, Yin S, Remick DG, Russell D, Eisenberg SP, Kohno T. Intratracheal administration of cndotoxin and cytokincs. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. Am ] Pathol 1993;i42:i335-i338.
25. Bachert C, Wagcnmann M, Häuser U. Proinflammatory cytokines: measurement in nasal secretion and induction of adhesion receptor expression. Int Arch Allergy Immunol 1995;i07:io6-iO7.